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As the patient had presented with suspected preterm labour, intramuscular steroids (two doses of dexamethasone 12 mg, given 12 hours apart) were administered to promote foetal lung maturity. The patient's BP remained normal throughout her pregnancy, with no paroxysmal hypertension. However, US of the hepatobiliary system was unremarkable.
Cushing's syndrome was suspected, and the diagnosis was confirmed with further workup, which showed a loss of diurnal rhythm of cortisol with raised 24-hour urinary free cortisol (Table II) . 
D I SCU S S IO N
Adrenal tumours in pregnancy are very rare, and antenatal diagnosis of this condition is difficult and often missed. (8) This underscores an important aspect of the modern management of these tumours. US is a valuable diagnostic tool in pregnancy, and when used to detect lesions of the adrenal glands, it has a reported sensitivity rate of 89%-97%. (9) Computed tomography is commonly used to localise adrenal masses and detect extra-adrenal or metastatic disease, with 94% sensitivity for tumours measuring more than 1 cm. However, in pregnancy, MR imaging is preferred so as to minimise radiation exposure. (10) Gadolinium, a United States Food and Drug Administration Category C agent, is usually contraindicated in pregnant women, and thus non-contrast-enhanced MR imaging is preferred. Adrenal phaeochromocytoma demonstrates a wide range of appearances on T2-weighted (T2-W) MR imaging.
In particular, a heterogeneously bright or hyperintense lesion on T2-W image (Fig. 2) is a useful diagnostic feature of phaeochromocytoma.
In Case 2, a diagnosis of Cushing's syndrome secondary to a cortisol-secreting adrenal adenoma was made. This condition rarely occurs in pregnant women, as hypercortisolism results in ovulatory disturbances and relative infertility. Making the diagnosis is important, as treatment improves outcome. In some early studies where the diagnosis of phaeochromocytoma was often not known antenatally, very high maternal and foetal mortality rates (48% and 54.4%, respectively) were reported. (2) Antenatal diagnosis and treatment, however, can reduce maternal mortality to 2%, (2) and medical management with an alpha-adrenergic blocker, such as phenoxybenzamine, has been found to be safe in pregnancy. Combined alpha-and beta-blockers, such as labetalol, have also been used in pregnancy with no adverse foetal effects. (2) The use of beta-blockers, which is important in preventing tachyarrythmia, should be kept to short-term usage in view of the possible risk of foetal growth restriction. (11) Medical treatment of phaeochromocytomas is necessary in order to facilitate surgery, as performing surgery in an untreated state can be life-threatening. Many authors have proposed a cut-off time of 24 weeks of gestation when considering surgical excision during pregnancy. This is because a large uterine size makes abdominal exploration difficult.
Surgical removal of the mass before 24 weeks of gestation usually has a good outcome, provided that medical therapy is adequate. (12) After 24 weeks of gestation, it may be advisable to discuss with the patient about delaying the treatment until reasonable foetal maturity is achieved. (13) In Case 1, surgical treatment after delivery was the better option, as the patient had been diagnosed late in the third trimester.
In Cushing's syndrome, antenatal diagnosis is also important, as untreated disease is associated with increased maternal mortality, preterm delivery and perinatal mortality.
As described in our two cases, we attempted delaying the deliveries till as near term as possible so as to allow foetal maturity. Higher dose steroids were also given to promote foetal lung maturity, as only a small amount of steroids in the maternal circulation reaches the foetal compartment in normal pregnancy, despite maternal hypercortisolism. This is because steroids are rapidly cleared from maternal plasma, and those that enter the throphoblast re-enter the maternal compartment instead of the foetal compartment. The conditions of both patients in this report were wellcontrolled with medical treatment, and the outcomes for both mothers and babies were good. Planned Caesarean C a s e R e p o r t e145 section is often preferred to spontaneous vaginal delivery in patients with phaeochromocytoma, based on the theoretical concern that bearing down efforts during labour could precipitate the release of catecholamines from the tumour. (2) Planned delivery in an elective setting also confers the benefit of ideal preoperative preparation in preventing a fatal crisis. Although vaginal delivery is not contraindicated in the presence of Cushing's syndrome, the presence of preeclampsia, placental insufficiency and the need to deliver the foetus at 30 weeks neccessitated a Caesarean section.
If adrenalectomy is to be performed after delivery of the foetus, this can be done as a one-stage procedure together with the Caesarean section or as an interval procedure after the puerperium, as was done in both our patients.
With the advent of minimally invasive procedures, laparoscopy has become the current surgical option of adrenalectomy, as opposed to a laparotomy. With decreased pain, shorter hospitalisation and recovery time, as well as improved patient satisfaction, laparoscopic adrenalectomy is the preferred approach for benign functioning or nonfunctioning tumours that measure less than 12 cm. (14) Laparoscopic adrenalectomy, especially for phaeochromocytoma, is a safe and effective procedure. The complication rate is less than 8% and operative mortality rate is less than 1% in experienced centres. (15) The laparoscopic approach was used in both our patients, although the patient in Case 1 eventually required a laparotomy due to the difficult operation.
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